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Abstract The purposes of this study were to determine
the effect of structural change on the intestinal disposi-
tion of isoflavones and to elucidate the mechanisms
responsible for transport of phase II isoflavone conju-
gates. Transport and metabolism of six isoflavones (i.e.,
genistein, daidzein, glycitein, formononetin, biochanin
A, and prunetin) were studied in the human intestinal
Caco-2 model and mature Caco-2 cell lysate. Glucuro-
nides were the main metabolites in intact Caco-2 cells for
all isoflavones except prunetin, which was mainly sul-
fated. In addition, the 7-hydroxy group was the main
site for glucuronidation whereas the 4¢-hydroxy group
was only one of the possible sites for sulfation. Glucu-
ronidated isoflavones (except biochanin A) were pref-
erably excreted to the basolateral side, whereas sulfated
metabolites (except genistein and glycitein) were mainly
excreted into the apical side. Polarized excretion of most
isoflavone conjugates was inhibited by the multidrug
resistance-related protein (MRP) inhibitor leukotriene
C4 (0.1 lM) and the organic anion transporter (OAT)
inhibitor estrone sulfate (10 lM). When formation and
excretion rates of isoflavones were determined simulta-
neously, the results showed that formation served as the
rate-limiting step for all isoflavone conjugates (both
glucuronides and sulfates) except for genistein glucuro-
nide, which had comparable excretion and formation
rates. In conclusion, the intestinal disposition of isof-
lavones was structurally dependent, polarized, and
mediated by MRP and OAT. Formation generally
served as the rate-limiting step in the cellular excretion
of conjugated isoflavones in the Caco-2 cell culture
model.
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Isoflavonoids belong to a class of plant non-nutrients
called phytoestrogens that have estrogen-like activities.
Epidemiological studies have shown that consumption
of an isoflavonoid-rich diet is associated with a decrease
in the incidence of hormone-related cancers (e.g., breast
and prostate cancer) ([1, 14, 24] and references therein).
Isoflavonoids are widely available as dietary supple-
ments in pharmacies and health food stores. The most
commonly consumed isoflavones are derived from soy
(mainly a mixture of genistein, daidzein, and glycitein)
and red clover (mainly a mixture of formononetin, bi-
ochanin A, genistein, and daidzein). Other popular
supplements that contain isoflavones also include black
cohosh (containing formononetin) and a mixture of soy
and black cohosh. Currently, soy isoflavones are
undergoing clinical trials for prostate cancer prevention.
Despite the assertion that isoflavones are effective
cancer prevention agents and have a variety of other
J. Chen Æ H. Lin Æ M. Hu (&)
Department of Pharmaceutical Sciences,
College of Pharmacy, Washington State University,




Present address: J. Chen
Department of Pharmaceutical Sciences,
College of Pharmacy, University of Michigan,
Ann Arbor, MI 48109-1065, USA
Present address: M. Hu
Department of Pharmacological and Pharmaceutical Sciences,
College of Pharmacy, University of Houston,
Houston, TX 77030, USA
Cancer Chemother Pharmacol (2005) 55: 159–169
DOI 10.1007/s00280-004-0842-x
health benefits, a significant gap exists between what has
been shown in vitro and what can be achieved in vivo.
This is because the in vivo concentration of intact isof-
lavones (nanomolar range) achieved with a normal soy
diet is much lower than that needed in vitro to achieve
their reported anticancer and chemopreventive effects,
which generally have IC50 values in the micromolar
range [1, 4, 14, 24]. The low bioavailability is usually not
the result of poor absorption but of extensive metabo-
lism as has been shown for genistein and apigenin [5, 15].
However, much work is needed to understand why
isoflavones have poor bioavailability so we can develop
isoflavones or their analogs into viable cancer chemo-
preventive agents.
Our understanding of the absorption mechanism and
metabolic pathways of isoflavones is limited, which
makes it difficult to understand the reasons for their
poor bioavailability. Previously, it has been also shown
that intestinal metabolism and subsequent metabolite
excretion is the main contributor of genistein’s first-pass
metabolism [5, 15]. Furthermore, the main metabolites
of genistein in Caco-2 cells are similar to those found in
humans in vivo, namely genistein glucuronide and gen-
istein sulfate [12, 13, 18]. Therefore, the goals of this
study were to characterize the metabolic pathways of six
isoflavones (i.e., genistein, daidzein, glycitein, formo-
nonetin, biochanin A, and prunetin; Fig. 1) and how
conjugated metabolites of isoflavones are excreted in the
Caco-2 cell culture model.
Materials and methods
Materials
Cloned Caco-2 TC7 cells were a kind gift from Dr.
Moniqué Rousset of INSERM U178 (Villejuit, France).
Leukotriene C4 was purchased from BIOMOL (Plym-
outh Meeting, Pa.). Isoflavones genistein, daidzein,
glycitein, formononetin, and prunetin were purchased
from Indofine Chemical Company (Wayne, N.J.) or LC
Laboratories (Woburn, Mass.). b-Glucuronidase with
sulfatase (catalog #G1512) or without sulfatase (catalog
#G7396), sulfatase without glucuronidase (catalog
#S1629), uridine diphosphoglucuronic acid, 3¢-phos-
phoadenosine 5¢-phosphosulfate, alamethicin, D-sac-
Fig. 1 HPLC elution profiles of six isoflavones (shown with
chemical structures) and their conjugated metabolites. Represen-
tative samples after 24-h incubation with the Caco-2 cell mono-
layers were used. Isoflavone glucuronides, sulfates, and their own
original aglycones (or isoflavones) are labeled G, S, and A,
respectively. Biochanin A (Bio) and prunetin (Pru) generated two
glucuronidated metabolites labeled G1 and G2, respectively. The
other four isoflavones, genistein (Gen), daidzein (Dai), glycitein
(Gly), and formononetin (For) only generated one sulfate and one
glucuronide. Testosterone was used as an internal standard (IS,
4 nmol), which had different retention times in two slightly
different HPLC methods (see ‘‘HPLC analysis of isoflavones and
their conjugates’’)
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charic-1,4-lactone monohydrate, biochanin A, magne-
sium chloride, estrone sulfate, and Hank’s balanced salt
solution (HBSS, powder form) were purchased from
Sigma Chemical Company (St Louis, Mo.). All other
materials (typically analytical grade or better) were used
as received.
Cell culture
The culture conditions for growing Caco-2 TC7 cells
have been described previously [8, 9, 15]. The seeding
density (100,000 cells/cm2), growth medium (DMEM
supplemented with 10% fetal bovine serum), and quality
control criteria were all implemented in the present
study as described previously [8, 9, 15]. Caco-2 TC7 cells
were fed every other day, and the monolayers were ready
for experiments from 19 to 22 days after seeding. The
TC7 strain of Caco-2 cells was developed in the labo-
ratories of Dr. Moniqué Rousset of INSERM U178
(Villejuit, France) and is generally similar to wild-type
Caco-2 cells used in our previous studies [10]. More than
55 published studies have used this strain of Caco-2 cells
according to a recent PubMed search.
Transport experiments in the Caco-2 cell culture model
Experiments in triplicate were performed in pH 7.4
HBSS [8, 9]. The protocol for performing cell culture
experiments was from those described previously [11].
Briefly, the cell monolayers were washed three times
with 37C pH 7.4 HBSS. The transepithelial electrical
resistance values were measured, and those with values
less than 420 Ohm cm2 were discarded. The monolayers
were incubated with the buffer for 1 h and the incuba-
tion medium was then aspirated. Afterwards, 2.5 ml of
an isoflavone solution was loaded onto the apical side
and 2.5 ml HBSS onto the basolateral side. Amounts of
transepithelial transport were followed as a function of
time, which was accomplished by four sequential sam-
ples every 30 min from the apical and basolateral sides.
After each sampling, the donor or the receiver side was
immediately replenished with the same volume (i.e.,
500 ll) of fresh isoflavone solution or HBSS, respec-
tively. As internal standard, 100 ll methanol/acetoni-
trile containing 100 lM testosterone was added to each
sample. The mixture was then centrifuged at 16,000 g
for 8 min, and the supernatant was analyzed by HPLC
(see below).
Caco-2 cell lysate
Six mature Caco-2 cell monolayers were removed with a
sharp blade from the culture inserts, immersed in 6 ml
50 mM potassium phosphate buffer (pH 7.4), and son-
icated in an Aquasonic 150D sonicator (VWR Scientific,
Bristol, Ct.) for 20 min at the maximum power (average
135 W) in an ice-cold water bath [11]. The resulting cell
lysate was then harvested and used fresh in the experi-
ments or frozen at 80C until use.
Lysate protein concentration
The concentrations of lysate protein were determined
using the Bio-Rad protein assay, using bovine serum
albumin as the standard.
Measurement of UGT activities using cell lysate
The incubation procedures for measuring UDP-glucu-
ronosyltransferase (UGT) activities using cell lysate
were as follows: (1) mix 135 ll cell lysate (final concen-
tration approximately 0.7 mg protein/ml), magnesium
chloride (0.88 mM), saccharolactone (4.4 mM), alame-
thicin (0.022 mg/ml), different concentrations of sub-
strates in a 50 mM potassium phosphate buffer
(pH 7.4), and uridine diphosphoglucuronic acid (UD-
PGA, 3.3 mM, add last) to a final volume of 200 ll; (2)
incubate the mixture at 37C for 120 min; (3) stop the
reaction by the addition of 50 ll 94% acetonitrile/6%
glacial acetic acid containing 100 lM testosterone as an
internal standard; (4) centrifuge the sample at 16,000 g
for 8 min; and (5) assay the sample via HPLC as de-
scribed below.
Measurement of sulfotransferase activities using
cell lysate
The incubation conditions for measuring sulfotransfer-
ase activities were as follows: (1) mix 90 ll cell lysate
(final concentration approximately 0.9 mg protein/ml),
3¢-phosphoadenosine 5¢-phosphosulfate (PAPS,
100 lM), and substrate of an appropriate concentration
(total volume 100 ll); (2) incubate the mixture at 37C
for 120 min; (3) stop the reaction by the addition of
25 ll 94% acetonitrile/6% glacial acetic acid containing
100 lM testosterone as an internal standard; (4) centri-
fuge the sample at 16,000 g for 8 min; and (5) assay the
sample via HPLC as described below.
Glucuronidated and sulfated isoflavones were iden-
tified by treating samples with b-glucuronidase or sul-
fatase, which would result in the disappearance of the
corresponding peaks in the relevant HPLC chromato-
grams.
HPLC analysis of isoflavones and their conjugates
The conditions for HPLC analysis of isoflavones were
modified based on a previously reported method [5]. The
conditions for analyzing isoflavones other than daidzein
and glycitein and their conjugates were: system, HP/
Agilent 1090 with a diode array detector and HP
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Chemstation; column, Aqua (Phenomenex, Guilory,
Calif.), 5 lm, 150·0.45 cm; mobile phase A, 0.04% (v/v)
phosphoric acid plus 0.06% (v/v) triethylamine (pH 2.8);
mobile phase B, 100% acetonitrile; mixed isocratic
gradient elution (0–3 min, 20% B; 2–22 min, 20–49% B;
22–23 min, 49% B), wavelength 254 nm; injection vol-
ume, 200 ll. The assay method for glycitein and daidz-
ein was similar to that for the other isoflavones but with
a small modification to the elution profile: mixed iso-
cratic gradient elution (0–3 min, 10% B; 3–19 min, 10–
34% B; 19–28 min, 34–52% B). There was a 5-min
interval between the end of the run and the next injec-
tion to allow the column re-equilibrate. Representative
profiles of six isoflavones and their conjugates are shown
in Fig. 1.
Data analysis
Rates of transport (Vt) were obtained using the con-
centration of transported isoflavones or their metabo-
lites as a function of time (Eq. 1). Permeability (P)
across a cellular membrane was calculated using the rate
of transport divided by the surface area (A) of the
monolayer and the initial concentration of these isof-
lavone compounds at the loading side (Ci; Eq. 2). Lastly,
the clearance (CLmt) of a metabolite from the cell
monolayer was defined as the rate of metabolite excre-
tion (Vmt) divided by the loading concentration (Eq. 3).













One-way ANOVA or Student’s t-test was used to ana-
lyze the data. The level of significance was set at 5% or
P<0.05.
Results
Apical to basolateral transport of intact isoflavones in
Caco-2 cell monolayers
Isoflavones genistein, daidzein, glycitein, biochanin A,
formononetin (10 lM dosing solution on the apical
side), and prunetin (5 lM dosing solution due to
solubility limit) were rapidly transported and metab-
olized during their transport from the apical to the
basolateral side. The amounts of isoflavones trans-
ported increased linearly as a function of time. The
apparent transport rates of intact isoflavones were
quite different and ranged from 4.77 to 20.82 pmol/
min/cm2 of cell membrane (P<0.05; Fig. 2). The
transport rate of glycitein was the fastest, followed
closely by genistein, then daidzein, biochanin A, and
formononetin (Fig. 2). The transport rate of prunetin
was determined at a concentration of 5 lM, and
Fig. 2 Initial transport rate and permeability of isoflavones in the
Caco-2 cell culture model. The first hour transport rate (bars, left
axis) and permeability (points, right axis) of genistein (Gen),
daidzein (Dai), glycitein (Gly), biochanin A (Bio), formononetin
(For), and prunetin (Pru) to the basolateral side in the cell culture
model were determined. The isoflavone concentration in the donor
solution was 10 lM except that of prunetin, which was 5 lM due
to solubility limitation. Transport experimental details and assay
conditions are described in ‘‘Materials and methods’’. Each point or
bar represents the average of three determinations, and the error
bars are the standard deviations of the means. *Significant
difference in the transport rate, one-way ANOVA; #significant
difference in the permeability value, one-way ANOVA
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therefore was not used in comparison because the rate
is dependent on concentration. The permeabilities of
these isoflavones (Fig. 2) followed the same trend as
the transport rate, except the permeability of prunetin
which was higher than that of biochanin A or for-
mononetin. We used 10 lM (except for prunetin) for
the rest of the study since this concentration is
achievable in vivo, and initial results showed sufficient
metabolites and aglycone on the donor and receiver
side to allow accurate measurement and the determi-
nation of inhibitor effects.
Excretion of isoflavone metabolites in intact
Caco-2 cell monolayers
We also followed the metabolism of all six isoflavones
after loading 10 lM of each isoflavone (5 lM for
prunetin due to solubility limitation) to the apical side.
Metabolites were excreted to both sides of the cell
monolayers, and the amounts of metabolites excreted
increased linearly as a function of time (Fig. 3).
The excretion of both conjugates was polarized and
the rates of conjugate excretion were determined
(Fig. 4). The efflux rates of glucuronides to the baso-
lateral side were higher (30–280%, P<0.05) than those
to the apical side, except for the efflux rates of biochanin
A glucuronide which were similar to both sides
(P>0.05). On the other hand, the sulfate efflux rates
favored the apical side for biochanin A, formononetin,
and prunetin (15–163% higher, P<0.05), but not for
daidzein (44% more to the basolateral side, P<0.05).
The effluxes were not polarized for genistein sulfate
(P>0.05; Fig. 4a) at this concentration.
Fig. 3a–d Time course of conjugate excretion in the Caco-2 cell
culture model. Amounts of the glucuronide and sulfate of genistein,
daidzein, glycitein, biochanin A, formononetin, and prunetin efflux
to both sides as a function of incubation time. The incubation time
points were 30, 60, 90 and 120 min for genistein, daidzein and
glycitein, and 60, 120, 180 and 240 min for biochanin A,
formononetin and prunetin. The prunetin concentration in the
donor solution was 5 lM, and the concentration of the other
isoflavones was 10 lM
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In addition to polarized excretion, the total amounts
of conjugates excreted from the Caco-2 cells were also
significantly different (P<0.05) among the five iso-
flavones (Fig. 4b). The total excretion rates of glucuro-
nide were the highest for glycitein (66.56 pmol/min per
monolayer or 15.85 pmol/min/cm2 for a monolayer of
4.2 cm2) followed by biochanin A, formononetin,
daidzein, and genistein (11.75 pmol/min per monolayer
or 2.80 pmol/min/cm2), whereas the total excretion rates
of sulfates in decreasing order were biochanin A
(15.95 pmol/min per monolayer, 3.8 pmol/min/cm2),
glycitein, genistein, daidzein, biochanin A, and formo-
nonetin (2.85 pmol/min per monolayer or 0.68 pmol/
min/cm2). On the other hand, the rank order of the total
clearance of glucuronide (which is the rate of glucuro-
nide excretion divided by the loading concentration of
parent compound) was slightly different: glycitein >
biochanin A> formononetin > prunetin > daidzein >
genistein. When comparing the total clearance of sul-
fates, prunetin showed the most rapid clearance because
its loading concentration was half that of the other
isoflavones.
Comparing the excretion rates of both conjugates
(Fig. 4a), the excretion rates of formononetin glucuro-
nide were much higher than those of its sulfate (19.5-
fold, P<0.05), and the excretion rates of glycitein,
daidzein and biochanin A, and genistein glucuronides
were also higher than that of their sulfates (4.5, 3.3, 2.0,
and 1.2-fold, respectively, P<0.05). In contrast, the
excretion rate of prunetin sulfate was much higher than
that of its glucuronide (2.1-fold, P<0.05).
The total conjugate excretion rates (Fig. 4b) in
decreasing order at 10 lM were: glycitein, biochanin A,
formononetin, daidzein and genistein, with values of
19.4, 16.2, 13.9, 5.7, and 5.2 pmol/min/cm2, respectively.
The total clearance values of conjugates, on the other
hand, were in the rank order: glycitein > biochanin A
> formononetin > prunetin > daidzein > genistein.
Effects of MRP and OAT inhibitors on excretion of
isoflavone metabolites in intact Caco-2 cells
The multidrug resistance-related protein (MRP) inhibi-
tor leukotriene C4 (LTC4, 0.1 lM) and the organic
anion transporter (OAT) inhibitor estrone sulfate
(10 lM) were used to determine the mechanisms by
which conjugated genistein and its analogs are
Fig. 4a, b Rates of conjugate
excretion in the Caco-2 cell
culture model. The polarized
excretion rate (a) and the total
excretion rate (b) of isoflavone
conjugates were determined at a
parent compound
concentration of 10 lM, except
for prunetin whose
concentration was 5 lM. The
transport experimental details
and the metabolite assay are
described in ‘‘Materials and
methods’’. Each bar represents
the average of three
determinations, and the error
bars are the standard deviations
of the means. *Significant
difference in the polarized
excretion rate (a) or types of
metabolites formed (b);
#significant differences in total
conjugate excretion rates of the
six isoflavones according to a
one-way ANOVA (b)
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Fig. 5a–d Effects of MRP and
OAT inhibitors on the excretion
of conjugated genistein and its
analogs in the Caco-2 cell
culture model. Genistein or its
analogs at 10 lM in dosing
solutions (prunetin at 5 lM)
were on the apical side of cell
monolayers, whereas MRP
inhibitor LTC4 (0.1 lM) or
OAT inhibitor estrone sulfate
(10 lM) were on both sides of
the monolayers. Excretion rates
of glucuronidated (a, b) and
sulfated (c, d) isoflavones to the
apical (a, c) and basolateral (b,
d) sides were determined in the
absence (control) or presence of
MRP inhibitor (LTC4) or OAT
inhibitor estrone sulfate (ES).
Transport experimental details
and the metabolite assay are
described in ‘‘Materials and
methods’’. Each bar represents
the average of three
determinations, and the error
bars are the standard deviations
of the means. *Significant




transported out of Caco-2 cells (Fig. 5). LTC4 or estrone
sulfate was present in the transport medium bathing
both sides of Caco-2 cell monolayers.
MRP inhibitor LTC4 (0.1 lM) significantly (P<0.05)
decreased the apical and basolateral efflux rates of gen-
istein, daidzein, glycitein, biochanin A, and for-
mononetin glucuronides, but did not affect the excretion
of prunetin glucuronide (P>0.05; Fig. 5a, b). LTC4 also
decreased the efflux rates (P<0.05) of genistein, daid-
zein, glycitein, and biochanin A sulfates from both sides,
but did not change the efflux rate of prunetin sulfate
(P>0.05). For formononetin sulfate, excretion from the
apical side was significantly decreased (P<0.05), but the
excretion from the basolateral side was increased by
36% (P<0.05; Fig. 5c, d).
Similar to the effects of LTC4, the OAT inhibitor
estrone sulfate also inhibited the excretion of genistein,
daidzein, glycitein, biochanin A, and formononetin
glucuronides from both sides of the cell monolayers
(P<0.05). However, it did not decrease the apical ex-
cretion of prunetin glucuronide (P>0.05; Fig. 5a, b).
Estrone sulfate also inhibited the efflux of genistein,
daidzein, glycitein, biochanin A, and prunetin sulfates
from both sides of cells (P<0.05), but did not decrease
the excretion of formononetin sulfate from the apical
side (P>0.05; Fig. 5c, d).
Formation rates of isoflavone conjugates in Caco-2 cell
lysate and comparison to their excretion rate in intact
cell monolayers
Glucuronidation and sulfation of six isoflavones (each at
10 lM, except prunetin at 5 lM) were determined using
Caco-2 cell lysate (Fig. 6) with a reaction time of
120 min and a protein concentration of about 0.7 mg/ml
based on preliminary studies that demonstrated linearity
for this length of reaction and enough metabolite pro-
duction at this protein concentration and time (not
shown). Similar to cellular excretion of isoflavone con-
jugates, formation rates of glycitein glucuronide and
sulfate (15.2 and 4.6 pmol/min per monolayer, respec-
tively) were the highest among these six isoflavones. In
addition, formation rates of genistein, glycitein, bioch-
anin A, and formononetin glucuronides were also much
higher (3.0 to 3.9-fold) than the formation rates of their
sulfates (P<0.05). In contrast, the sulfation rate of
daidzein was higher (20%, P<0.05) than its glucur-
onidation rate but the difference (20%) was much
smaller than for prunetin (120% higher sulfation rate,
P<0.05).
To facilitate the comparison of formation and
excretion, both the formation rate (picomoles per min-
ute per milligram) and excretion rate were converted to
the unit of picomoles per minute per monolayer. When
excretion rates were plotted against formation rates,
formation rates were the rate-limiting step in cellular
excretion for all the isoflavone conjugates except for
genistein glucuronide, whose formation and excretion
rates were similar.
Discussion
Many isoflavones undergo extensive conjugated metab-
olism in rats and humans [4, 5, 15, 18]. The conjugated
isoflavones are present at a much higher concentrations
than their aglycone forms in human blood [4, 18]. In a
rat perfusion model, genistein conjugates but not intact
genistein can be detected in blood [5]. Our previous
studies have also indicated that the intestine is the main
site of genistein conjugation and that intestinal conju-
gation enables enteric recycling of genistein [5]. In the
present study, we compared intestinal disposition of six
isoflavones. This study focused on the effects of structure
on the excretion of conjugated metabolites, mechanisms
Fig. 6 Effects of structural
change on the formation and
excretion of isoflavone
conjugates. Genistein and its
analogs (10 lM) were
incubated in the
glucuronidation or sulfation
reaction mixture solution with
cell lysate (about 0.7 mg/ml) for
120 min. Formation rates
(pmol/min per mg of protein) of
glucuronidated and sulfated
isoflavones were determined
and plotted along with the
corresponding excretion rates.
Each bar represents the average
of three determinations, and the
error bars are the standard
deviations of the means.
*Significant difference between
excretion rate and formation
rate, Student’s t-test
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of conjugated excretion, and the determination of the
rate-limiting step in the cellular excretion of isoflavone
conjugates.
Both the cell lysate model and the intact Caco-2 cell
culture model were used for the present study because
together they can provide more useful information than
either model alone. The cell lysate model is best used to
determine the formation rates that reflect the metabolic
rate of a compound. The intact cell culture model is best
used to determine the cellular excretion of metabolites.
Excretion is a more complex process than metabolite
formation, but is more reflective of what may occur in
vivo. This is because multiple metabolic pathways are
present in the cells and excretion may limit the forma-
tion of a particular metabolite [11]. In other words,
conjugated metabolites inside the cytosolic domain must
be efficiently pumped out of the cells to achieve rapid
excretion. Accumulation of metabolites inside cells due
to lack of excretion could cause ‘‘product inhibition’’ of
the enzyme reaction or lead to reconversion back to the
aglycones via the action of hydrolases (e.g., glucuroni-
dase and sulfatase). Therefore, the intact cell model can
be used to measure the coupling effects of conjugation
enzyme and efflux transporters.
Our studies demonstrated that the transport rates of
intact isoflavones (the parent compounds, aglycone) in
the Caco-2 cell model were all rapid but there were
substantial differences in the apparent rate of transport
(Fig. 2). Many isoflavones are also extensively metabo-
lized during transport and there was no apparent rela-
tionship between total conjugate excretion rates and
apparent rates of transport or permeabilities. However,
if we defined the total uptake rates of isoflavones as rates
of intact isoflavone transport (Fig. 2) plus total rates of
conjugate excretion, since conjugating enzymes are
present inside the cells (Fig. 4b), the highest uptake was
achieved with glycitein, followed by biochanin A, geni-
stein, daidzein, and formononetin. Prunetin was not
used for comparison because it was used at a lower
concentration. Its total rate of uptake would have been
slightly higher than that of formononetin if we assume
that a doubling of concentration will result in a doubling
of transport rates and excretion rates. This result dem-
onstrated that changes in isoflavone structure would
affect total uptake and cellular excretion of metabolites.
The polarization of the excretion rates of conjugates
was also highly dependent on the isoflavone structure.
All isoflavone glucuronides except biochanin A glucu-
ronide were mainly excreted to the basolateral side,
whereas biochanin A glucuronide were excreted equally
to both sides (Fig. 4). In addition, the sulfates of three of
the six isoflavones (biochanin A, formononetin, and
prunetin) were mainly excreted apically, whereas daidz-
ein sulfate was mainly to the basolateral side. The
remaining two isoflavone sulfates were not preferentially
distributed at this concentration (Fig. 4).
In order to determine the rate-limiting step of isof-
lavone conjugate excretion at 10 lM for all isoflavones
except prunetin, we determined the formation and
excretion rates and normalized these rates to a ‘‘per
monolayer’’ basis (Fig. 6). The glucuronide formation
rate was much lower than the excretion rate for all
isoflavones except genistein, whose formation rate was
similar to its excretion rate. Assuming the lower rate was
the rate-limiting step, glucuronide formation was the
rate-limiting step for all isoflavones except genistein. For
isoflavone sulfates, the sulfate formation rate always
represented the rate-limiting step. Taken together, these
results indicate that conjugate formation is the rate-
limiting step in the cellular excretion of isoflavone con-
jugates. Coupling of the conjugating enzymes and efflux
transporters determines the rate and direction of con-
jugate excretion, based on the assumption that these
hydrophilic conjugates are evenly distributed within the
cellular water space.
To further study the effect of structural change on
conjugation, we sought to determine how a change in
the number and position of hydroxy groups would affect
their conjugation pathways. Previous studies has shown
that isoflavone glucuronidation mostly occurs at the
7-hydroxyl position whereas sulfation mostly occurs at
the 4¢-hydroxy group [12, 18]. In the present study,
blockage of the 4¢-hydroxyl position diminished but did
not prevent sulfation in the Caco-2 cell lysate when the
only metabolic pathway was sulfation (because of the
presence of co-enzyme PAPS). For example, biochanin
A and formononetin were both sulfated. However, the
rate of sulfation was typically lower than the rate of
glucuronidation for an isoflavone with 7-hydroxyl and
4¢-methoxy groups (e.g., formononetin). These results
suggest that sulfation could occur at a hydroxy group
other than 4¢-hydroxyl. In contrast to sulfation, glucu-
ronidation appeared to mainly occur at the 7-hydroxy
group since the only compound with a blocked 7-hy-
droxy group (i.e., prunetin) was very poorly glucuroni-
dated (Fig. 6).
In the intact cell culture model, in which an isoflav-
one could either be glucuronidated or sulfated, the
preference for glucuronidation (at the 7-hydroxy group)
over sulfation (at the 4¢-hydroxy group) was more
obvious. For example, excretion rates of the glucuro-
nides of biochanin A and formononetin (both lacking
the 4¢-hydroxy group) were much higher than that of
their sulfates (Fig. 6). In contrast, the excretion rate of
prunetin sulfate was more than double that of prunetin
glucuronide. For isoflavones which have both hydroxy
groups (7 and 4¢ positions) available (genistein and
glycitein), the main excretion products were also glucu-
ronides. Taken together, these results indicate a prefer-
ence for glucuronidation over sulfation for the six
isoflavones at this concentration. In addition, the 7-hy-
droxy group remains a major site of isoflavone glucu-
ronidation, whereas the 4¢-hydroxy group is only one of
the sites for isoflavone sulfation since compounds
without a 4¢-hydroxy group were sulfated at approxi-
mately the same rates.
We next determined the mechanisms responsible for
the conjugate efflux employing the MRP inhibitor LTC4
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and the OAT inhibitor estrone sulfate. LTC4 inhibited
the apical and basolateral efflux of five isoflavone glu-
curonides but not that of prunetin glucuronide (Fig. 5a,
b). Estrone sulfate was similarly effective in inhibiting
the efflux of isoflavone glucuronides from both the api-
cal and the basolateral domains, except it did not change
the apical efflux of prunetin glucuronide (Fig. 5a, b).
These results suggest that excretion of isoflavone glu-
curonides is mediated by MRP and OAT. Based on
earlier observations that Caco-2 cells mostly express
MRP2 and MRP3 with low expression of MRP1 and
MRP5 [7, 22], and that MRP3 and MRP2 are located at
the basolateral and apical membranes of the Caco-2 cells
[2, 3, 22]. MRP3 and MRP2 are probably responsible for
the efflux of isoflavone glucuronides since they have been
shown to be involved in the excretion of flavone conju-
gates [11, 16, 21, 23]. On the other hand, OAT4 is
probably also involved in the cellular excretion of isof-
lavone glucuronides since this organic efflux transporter
is capable of exporting cellular organic anions [17].
The effects of these two efflux transporter inhibitors
on sulfate excretion were mostly similar to their effects
on glucuronide excretion. However, LTC4 was not
effective in inhibiting the efflux of formononetin and
prunetin sulfates, whereas estrone sulfate was not
effective in inhibiting the basolateral efflux of formo-
nonetin sulfate. Estrone sulfate was, somewhat surpris-
ingly, highly effective against the apical and basolateral
excretion of prunetin conjugates, inhibiting its excretion
by more than 80% from both sides.
Taken together, the results of our study clearly
demonstrate that human intestinal Caco-2 cells can
form isoflavone conjugates, and the conjugated
metabolites of isoflavones are excreted into both the
apical and basolateral sides. Our results also indicate
that the formation of conjugates and excretion of
conjugated metabolites are coupled, which is an
enabling process for enteric recycling [15]. Together
with enterohepatic recycling proposed previously by
other investigators, these recycling mechanisms help
explain the pharmacokinetic behavior of isoflavonoids.
In other words, as a consequence of this recycling, the
apparent plasma half-lives of isoflavonoids (e.g., geni-
stein) after oral administration are greatly increased
(typically more than 5 h [4, 6, 19, 20]) when compared
to i.v. administration (typically less than 1 h [6]). In
essence, coupling-enabled recycling processes (e.g., en-
teric and enterohepatic recycling) are critical for the
biological effects of isoflavonoids, because they allow
these molecules to stay in vivo for a much longer
period of time. The prolonged presence in the systemic
circulation enables these compounds to display pro-
longed antioxidant effects in vivo, and provides the
opportunity for their conversion into more active
aglycones at the target tissues by the action of conju-
gate hydrolases (i.e., sulfatase and glucuronidase).
In summary, our results suggest that changes in the
structure of isoflavones affects the type of conjugates
formed, and rate of conjugate excretion. In human
intestinal Caco-2 cells, glucuronidation primarily
occurs at the 7-hydroxyl position and is the main
metabolic pathway. On the other hand, sulfation
appears to occur at positions in addition to the
4¢-hydroxyl position as described in the literature and
is the secondary metabolic pathway for isoflavones
other than prunetin. Conjugated metabolites are
excreted via the action of MRPs and OATs, since their
excretion was inhibited by prototypical inhibitors of
these efflux transporters.
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